Hemagen Diagnostics, Inc. is a biotechnology company. The company is headquartered in Columbia, Maryland and currently employs 15 full-time employees. The firm is primarily focused on Veterinary Clinical Diagnostics. The company is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. The firm develops, manufactures and markets a range of test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. The Company’s autoimmune product portfolio includes Hemagen DNA Kit, Hemagen Rheumatoid Factor Kit, VIRGO AMA IgG, VIRGO ANA/Hep-2 IgG, VIRGO Anti-nDNA IgG, VIRGO cANCA (PR-3) Kit, VIRGO dsDNA Kit, VIRGO ENA Screen 6 Kit, VIRGO ENA Screening, VIRGO ENA Series, VIRGO pANCA myeloperoxidase (MPO) Kit and VIRGO Rheumatoid Factor Kit. The company offers various products for infectious disease, which includes VIRGO C. trach IgG, VIRGO CMV IgG and VIRGO epstein-barr virus (EBV)- viral capsid antigen (VCA) IgG. Its products are used in laboratories, hospitals and blood banks around the world.
Follow-Up Questions
¿Quién es el CEO de Hemagen Diagnostics Inc?
William Hales es el Chairman of the Board de Hemagen Diagnostics Inc, se unió a la empresa desde 1999.
¿Qué tal es el rendimiento del precio de la acción HMGN?
El precio actual de HMGN es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Hemagen Diagnostics Inc?
Hemagen Diagnostics Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Hemagen Diagnostics Inc?
La capitalización bursátil actual de Hemagen Diagnostics Inc es $0